CND Life Sciences’ Post

View organization page for CND Life Sciences, graphic

1,391 followers

The publication of the Synuclein-One Study in JAMA, Journal of the American Medical Association continues to draw media attention. Last week, Christopher Gibbons, MD, lead author of the study and Professor of Neurology at Harvard Medical School was interviewed on CBS News. Dr. Gibbons explained why clinicians can’t always rely on symptoms alone to diagnose neurodegenerative disorders like #ParkinsonsDisease and #DementiaWithLewyBodies, how the Syn-One Test® can help provide a diagnosis several years before symptoms develop, and what that could mean for patients when new treatments are developed.  Watch the interview. https://lnkd.in/g3hFWAyu CND Life Sciences Rick Morello Todd Levine #msa #neurology  

  • No alternative text description for this image
Philip Fortier

Rare Disease KOL, Educator & Advocate for people with Multiple System Atrophy & Atypical Parkinson’s

7mo

Great to hear that the Syn-One Test is getting more attention!

Dan Newcome

In search of a challenging opportunity where I can use my past experiences in commodities and as a veteran.

7mo

This is great news! Maybe doctors will start using this great resource.

Molly White Jones

Director of Marketing | Biotech + Diagnostic + Med Device + Equipment + Healthcare Technology + Dental Recruiting

7mo

Very impressive!

See more comments

To view or add a comment, sign in

Explore topics